NICHOLAS CAPALDO
CUYAHOGA FLS, OH
Browse related groups: OH Novo Nordisk AS All categories
This page merges CMS profile IDs: 8801936, 8807152 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$1,926.91
- Category: General Payments
- Program years: PY2020–2024
- Record count: 80
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,198.19 across 63 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,198.19 | 63 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $197.91 | 10 |
| Lundbeck LLC | $177.52 | 10 |
| ABBVIE INC. | $139.05 | 11 |
| Teleflex LLC | $109.22 | 1 |
| Acerta Pharma LLC | $68.70 | 4 |
| Vanda Pharmaceuticals Inc. | $48.51 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $47.41 | 2 |
| GlaxoSmithKline, LLC. | $42.78 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $35.51 | 2 |
| Lilly USA, LLC | $35.48 | 2 |
| Janssen Pharmaceuticals, Inc | $34.10 | 2 |
| Sumitomo Pharma America, Inc. | $30.87 | 2 |
| PFIZER INC. | $30.45 | 2 |
| Esperion Therapeutics, Inc. | $25.85 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.62 | 1 |
| Actelion Pharmaceuticals US, Inc. | $21.11 | 1 |
| Inspire Medical Systems, Inc. | $21.03 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.78 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.37 | 1 |
| Amgen Inc. | $16.53 | 1 |
| OptiNose US, Inc. | $16.20 | 1 |
| Axsome Therapeutics, Inc. | $14.43 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.13 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.63 | 1 |
By program year
Records — PY2024 (63)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 8801936, 8807152
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.